Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dagmar Kunz

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
European Cytokine Network|January 13, 2004
The cytokine synthesis by heterozygous carriers of the Toll-like receptor 4 Asp299Gly polymorphism does not differ from that of wild type homozygotesMichael Heesen, Brunhilde Bloemeke, Dagmar Kunz
American Journal of Hematology|May 8, 2002
Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusionRolf Dario Frank, Dagmar Kunz, Dieter Christian Wirtz
Critical Care Medicine|May 7, 2002
Can the interleukin-6 response to endotoxin be predicted? Studies of the influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and inflammatory cytokinesMichael Heesen, Brunhilde Bloemeke, Nicole Heussen, et al.
European Cytokine Network|July 9, 2002
The CD14-260 C --> T promoter polymorphism co-segregates with the tumor necrosis factor-alpha (TNF-alpha)-308 G --> A polymorphism and is associated with the interleukin-1 beta (IL-1 beta) synthesis capacity of human leukocytesMichael Heesen, Brunhilde Bloemeke, Bernd Bachmann-Mennenga, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 18, 2003
Rapid and reliable genotyping for the Toll-like receptor 4 A896G polymorphism using fluorescence-labeled hybridization probes in a real-time polymerase chain reaction assayMichael Heesen, Martina Wessiepe, Dagmar Kunz, et al.
Methods in Enzymology|July 20, 2002
Functional imaging of mitochondrial redox stateDagmar Kunz, Kirstin Winkler, Christian E Elger, et al.
Resuscitation|October 29, 2003
Procalcitonin serum levels after out-of-hospital cardiac arrestMichael Fries, Dagmar Kunz, Axel M Gressner, et al.
Clinical Chemistry and Laboratory Medicine|May 19, 2004
Comparison of three commercial assays for the measurement of 17alpha-hydroxyprogesterone (17alpha-OHPR): limitations of the quality control systemUrsula Meier, Claudia Schnabel, Dagmar Kunz, et al.
Journal of the American College of Cardiology|September 3, 2002
brain natriuretic peptide levels predict functional capacity in patients with chronic heart failureStefan Krüger, Jürgen Graf, Dagmar Kunz, et al.
Critical Care Medicine|January 25, 2003
Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulationMichael Heesen, Dagmar Kunz, Bernd Bachmann-Mennenga, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
European Cytokine Network|January 13, 2004
The cytokine synthesis by heterozygous carriers of the Toll-like receptor 4 Asp299Gly polymorphism does not differ from that of wild type homozygotesMichael Heesen, Brunhilde Bloemeke, Dagmar Kunz
American Journal of Hematology|May 8, 2002
Acquired von Willebrand disease--hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusionRolf Dario Frank, Dagmar Kunz, Dieter Christian Wirtz
Critical Care Medicine|May 7, 2002
Can the interleukin-6 response to endotoxin be predicted? Studies of the influence of a promoter polymorphism of the interleukin-6 gene, gender, the density of the endotoxin receptor CD14, and inflammatory cytokinesMichael Heesen, Brunhilde Bloemeke, Nicole Heussen, et al.
European Cytokine Network|July 9, 2002
The CD14-260 C --> T promoter polymorphism co-segregates with the tumor necrosis factor-alpha (TNF-alpha)-308 G --> A polymorphism and is associated with the interleukin-1 beta (IL-1 beta) synthesis capacity of human leukocytesMichael Heesen, Brunhilde Bloemeke, Bernd Bachmann-Mennenga, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 18, 2003
Rapid and reliable genotyping for the Toll-like receptor 4 A896G polymorphism using fluorescence-labeled hybridization probes in a real-time polymerase chain reaction assayMichael Heesen, Martina Wessiepe, Dagmar Kunz, et al.
Methods in Enzymology|July 20, 2002
Functional imaging of mitochondrial redox stateDagmar Kunz, Kirstin Winkler, Christian E Elger, et al.
Resuscitation|October 29, 2003
Procalcitonin serum levels after out-of-hospital cardiac arrestMichael Fries, Dagmar Kunz, Axel M Gressner, et al.
Clinical Chemistry and Laboratory Medicine|May 19, 2004
Comparison of three commercial assays for the measurement of 17alpha-hydroxyprogesterone (17alpha-OHPR): limitations of the quality control systemUrsula Meier, Claudia Schnabel, Dagmar Kunz, et al.
Journal of the American College of Cardiology|September 3, 2002
brain natriuretic peptide levels predict functional capacity in patients with chronic heart failureStefan Krüger, Jürgen Graf, Dagmar Kunz, et al.
Critical Care Medicine|January 25, 2003
Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulationMichael Heesen, Dagmar Kunz, Bernd Bachmann-Mennenga, et al.
Pageof 4